Future Rheumatology

PTPN22: a confirmed rheumatoid arthritis susceptibility gene?
pp. 153-158(6)
Author: Hinks, Anne

Extracorporeal shock waves and bone: can we shock the cells into growth?
pp. 159-162(4)
Authors: Hausdorf, J; Maier, M

Efficacy of glucosamine and chondroitin sulfate linked to degree of pain
pp. 163-165(3)

Role of abetimus in systemic lupus erythematosus
pp. 167-171(5)
Authors: Joshi, Manuja; Madaio, Michael P

Gene therapy with the interleukin-1 receptor antagonist for the treatment of arthritis
pp. 173-178(6)
Authors: Evans, Christopher H; Ghivizzani, Steven C; Wehling, Peter; Robbins, Paul D

Hematopoietic and mesenchymal stem cell transplantation in autoimmune diseases
pp. 179-188(10)
Authors: Tyndall, Alan; Dazzi, Francesco

How does HLA-B27 affect susceptibility to spondyloarthropathy?
pp. 189-197(9)
Authors: Goodall, Jane C; Gaston, JSH

Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?
pp. 199-206(8)
Authors: Bruyere, Olivier; Reginster, Jean-Yves

Meniscectomy and osteoarthritis: what is the cause and what is the effect?
pp. 207-215(9)
Authors: Englund, Martin; Lohmander, L Stefan

Novel hints on the pathogenesis of lupus from in vivo models
pp. 217-224(8)
Authors: Rovere-Querini, Patrizia; Sabbadini, Maria Grazia; Di Comite, Gabriele; Manfredi, Angelo A

Antimalarials in systemic lupus erythematosus: benefits beyond disease activity
pp. 225-233(9)
Authors: Andrade, Rosa M; Alarcón, Graciela S

New therapies for systemic lupus erythematosus: has the future arrived?
pp. 235-247(13)
Authors: Kaul, Arvind; D'Cruz, David; Hughes, Graham RV

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
pp. 249-258(10)
Authors: Yamada, Ryo; Suzuki, Akari; Yamamoto, Kazuhiko

Potential role of statins and PPARs in rheumatoid arthritis
pp. 259-274(16)
Authors: Douglas, Karen MJ; Sattar, Naveed; Kitas, George D